Physician profile
Joseph Deluca
NPI 1205916509
$4,906.38
in general payments reported to CMS, 2019-2025
12 companies · $951 in 2025
The $951 reported for 2025 was more than what 87% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $278 · 2020: $110 · 2021: $631 · 2022: $1,199 · 2023: $521 · 2024: $1,217 · 2025: $951.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,689.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,688.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,640.08 | 2019-2025 | Clareon, Centurion, Hydrus Microstent |
| Glaukos Corporation | $1,364.48 | 2021-2025 | Idosetr, Istent |
| Johnson & Johnson Surgical Vision, INC. | $182.62 | 2019-2023 | Tecnis Simplicity |
| Sight Sciences, INC. | $171.68 | 2022-2025 | Omni Surgical System, Sion Surgical Instrument |
| Tarsus Pharmaceuticals, INC. | $131.87 | 2024-2025 | Xdemvy |
| Allergan, INC. | $110.25 | 2019-2021 | |
| Oyster Point Pharma, INC. | $79.95 | 2022-2025 | Tyrvaya, Ryzumvi |
| Ocular Therapeutix, INC. | $74.94 | 2021-2025 | Dextenza |
| Novartis Pharmaceuticals Corporation | $64.12 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $42.97 | 2019-2020 | |
| Eyevance Pharmaceuticals LLC | $30.00 | 2022 | |
| Shire North American Group INC | $13.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Deluca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.